Evaluating the Trend of VRE carriages in Health Facilities: A Retrospective Study from 2019-2022
Keywords:
Healthcare Associated Infection, Vancomicin-Resistant Enterococci, Hospitalization, Infection control.Abstract
Background. Healthcare-associated infections (HAIs) and multidrug resistance (MDR) are a growing public health threat and pose a risk to patient safety in healthcare facilities. Vancomycin-resistant Enterococci (VRE) are responsible for nosocomial infections and have intrinsic and acquired resistance to many antibiotics, including glycopeptides. VRE carriage can remain undetected, increasing the risk of contact transmission. Identifying colonized patients is crucial for the implementation of preventive measures.
Aims. The aims of this study were to evaluate the trend of VRE carriage based on rectal swab results between 2019 and February 2022 in a large Italian trust and the percentage of patients with VRE colonization at the time of hospitalization.
Methods. This was a retrospective observational study based on results of rectal swabs performed for screening on admission between January 2019 and February 2022 in four hospitals part of a single trust in Turin, North-Western Italy. The study collected data on the date of specimen collection, type of specimen, isolated pathogen and the date of hospital admission. Descriptive analysis of data was performed, and duplicate samples were not considered.
Results. From January 2019 to February 2022 we collected 5025 rectal swabs performed in hospitals of the trust, of which 3037 were performed in 2019 (60%), 741 in 2020 (15%), 611 in 2021 (12%) and 636 in the first two months of 2022 (13%). VRE positivity was found in 162 (3%) rectal swabs, of which 2 cases in both 2019 (0.1%) and 2020 (0.3%), 95 in 2021 (15.5%) and 63 in the first two months of 2022 (9.9%). Furthermore, 52% (84/162) of positive rectal swabs were performed at admission, whereas the remaining 48% (78/162) of positive rectal swabs were performed after 48h.
Conclusions. This study found an increasing trend of VRE carriage in the study population during the SARSCoV-2 pandemic, highlighting the importance of screening patients for VRE carriage to prevent worsening clinical conditions, environmental contamination, and prolonged hospitalization.
References
1. Bordino V, Vicentini C, D’Ambrosio A, et al. Burden of healthcare-associated infections in Italy: incidence, attributable mortality and disability-adjusted life years (DALYs) from a nationwide study, 2016. J Hosp Infect. 2021 Jul
1; 113: 164-71. doi: 10.1016/j.jhin.2021.04.023. Epub 2021 May 1.
2. García-Solache M, Rice LB. The enterococcus: A model of adaptability to its environment.Clin Microbiol Rev. 2019 Jan 30; 32(2): e00058-18. doi: 10.1128/CMR.00058-18.
3. Efe Iris N, Sayíner H, Yíldírmak T, Simsek F, Arat ME. Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors. Am J Infect Control. 2013 Mar; 41(3): 261-2. doi: 10.1016/j.ajic.2012.04.331. Epub 2012 Oct 13.
4. Vehreschild MJGT, Haverkamp M, Biehl LM, Lemmen S, Fätkenheuer G. Vancomycinresistant enterococci (VRE): a reason to isolate?
Infection. 2019 Feb; 47(1): 7-11. doi: 10.1007/ s15010-018-1202-9. Epub 2018 Sep 3.
5. Mühlberg E, Umstätter F, Kleist C, Domhan C, Mier W, Uhl P. Renaissance of vancomycin: Approaches for breaking antibiotic resistance in multidrug-resistant bacteria. Can J Microbiol. 2020 Jan; 66: 11-6. doi: 10.1139/cjm-20190309.
6. WHO Regional Office for Europe, European Centre for Disease Prevention and Control (Ecdc). Antimicrobial resistance surveillance in Europe, 2022 - 2020 data. Copenhagen: ECDC, 2022.
7. Iacchini S, Pezzotti P, Caramia A, et al. AR-ISS: sorveglianza nazionale dell’Antibiotico-Resistenza. Dati 2021. [Internet]. ROMA: Istituto Superiore di Sanità; 2022; 2021. Available from: https://www.iss.it/documents/20126/6703853/ RIS-1_2022.pdf/0d8ac191-5886-c5cb-75893cee93040575?t=1668687989078.
8. Fukushige M, Syue LS, Morikawa K, et al. Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed. J Microbiol Immunol Infect.
2022 Dec; 55(6 Pt 2): 1211-8. doi: 10.1016/j. jmii.2022.08.003. Epub 2022 Aug 7.
9. Shbaklo N, Corcione S, Vicentini C, et al. An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs. Antibiotics (Basel). 2022 May 20; 11(5): 695. doi: 10.3390/antibiotics11050695.
10. Suh JW, Kim NH, Lee MJ, et al. Real-world experience of how chlorhexidine bathing affects the acquisition and incidence of vancomycin-resistant enterococci (VRE) in a medical intensive care unit with VRE endemicity: a prospective interrupted time-series study. Antimicrob Resist Infect Control. 2021 Nov 10; 10(1): 160. doi: 10.1186/s13756-021-01030-6.
11. Karaşin G, Bayram Y, Parlak M, Aypak C, Akgül M, Güdücüoglu H. The evaluation of vancomycin-resistant enterococci and carbapenamase producing Klebsiella colonization among ICUHospitalized Patients. Afr Health Sci. 2021 Dec; 21(4): 1662-8. doi: 10.4314/ahs.v21i4.20.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 A. Cremona, V. Bordino, C. Vicentini, M. Morandi, R. G. Vecchietti, C.M. Zotti (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.